» Articles » PMID: 27883196

Grifolin Derivatives from Albatrellus Ovinus As TRPV1 Receptor Blockers for Cosmetic Applications

Overview
Specialty Dermatology
Date 2016 Nov 25
PMID 27883196
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Blocking the TRPV1 receptor is an interesting approach for the treatment of sensitive skin. Here we investigated the potential of grifolin derivatives from Albatrellus ovinus to act as TRPV1 receptor blockers and their potential to serve as cosmetic active ingredients.

Methods: Binding characteristics of grifolin derivatives from Albatrellus ovinus were determined in competitive and functional in vitro assays to achieve IC values. The TRPV1 receptor was activated in vivo with capsaicin and noxious heat to investigate skin reddening, microcirculation, skin sensations and heat pain thresholds.

Results: Grifolin derivatives extracted from Albatrellus ovinus proved to inhibit the TRPV1 receptor in vitro and in vivo. Besides suppression of the TRPV1 receptor activity upon chemical stimulation with capsaicin, thermal activation was shown to be inhibited as well by application of cosmetic formulations containing 3% Albatrellus ovinus extract. The reduction of stinging and burning sensations as well as reduction of reddening and microcirculation upon irritation with capsaicin or thermal stress proved efficacy in vivo.

Conclusion: Grifolin derivatives from Albatrellus ovinus are able to serve as fungal-derived TRPV1 receptor blockers with capability to serve as a cosmetic active ingredient on sensitive skin.

Citing Articles

A Randomized, Single-Center, Double-Blind, Controlled Case Study Evaluating Procedure Pairing of a Neurocosmetic Postprocedure Cream With Radiofrequency Microneedling for Facial Rejuvenation.

Maloney M, Iglesia S, Kononov T, Zahr A, Gold M J Cosmet Dermatol. 2024; 23(12):4077-4084.

PMID: 39385645 PMC: 11626329. DOI: 10.1111/jocd.16622.


Microneedling with a Novel, n-3-PUFA-Rich Formulation Accelerates Inflammation Resolution to Improve Skin Recovery Outcomes in Adults with Healthy Skin.

Wong R, Murphy A, Lira M, Sichmann M, Kim A, Saechee V Dermatol Ther (Heidelb). 2023; 13(12):3057-3069.

PMID: 37833618 PMC: 10689607. DOI: 10.1007/s13555-023-01049-0.


Natural Active Ingredients and TRPV1 Modulation: Focus on Key Chemical Moieties Involved in Ligand-Target Interaction.

Andrei C, Zanfirescu A, Nitulescu G, Olaru O, Negres S Plants (Basel). 2023; 12(2).

PMID: 36679051 PMC: 9860573. DOI: 10.3390/plants12020339.


Pharmacological Effects of Grifolin: Focusing on Anticancer Mechanisms.

Bouyahya A, El Allam A, Zeouk I, Taha D, Zengin G, Goh B Molecules. 2022; 27(1).

PMID: 35011516 PMC: 8746472. DOI: 10.3390/molecules27010284.